Novo Nordisk to cut 9,000 jobs as Eli Lilly competition intensifies
The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity drug market.
The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity drug market.
What's Your Reaction?
